4//SEC Filing
Mottiwala Aziz 4
Accession 0001209191-23-035579
CIK 0001819790other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 7:16 PM ET
Size
11.2 KB
Accession
0001209191-23-035579
Insider Transaction Report
Form 4
Mottiwala Aziz
Chief Commercial Officer
Transactions
- Sale
Common Stock
2023-06-07$19.34/sh−2,500$48,350→ 48,186 total - Sale
Common Stock
2023-06-06$18.61/sh−2,143$39,881→ 50,686 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.
- [F2]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $18.07 to $18.86. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $19.02 to $19.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001788542
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 7:16 PM ET
- Size
- 11.2 KB